---
title: "Connplex Cinemas Ltd (CONNPLEX) — Share Price, Financials & Analysis"
symbol: "CONNPLEX"
company: "Connplex Cinemas Ltd"
canonical: "https://tapetide.com/stocks/CONNPLEX"
isin: "INE0EAS01014"
nse_symbol: "CONNPLEX"
sector: "Media"
industry: "Film Production Distribution"
market_cap_cr: 481.32
generated_at: "2026-09-13T19:29:34.398Z"
---

# Connplex Cinemas Ltd (CONNPLEX)

Canonical page: https://tapetide.com/stocks/CONNPLEX

## Company

- **NSE Symbol:** CONNPLEX
- **ISIN:** INE0EAS01014
- **Sector:** Media
- **Industry:** Film Production Distribution
- **Macro Sector:** Consumer Discretionary
- **Stock Type:** EQUITY
- **Listed Since:** 2025-08-14
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** theconnplex.com

## About

Incorporated in 2015, Connplex Cinemas Ltd is in the business of running a chain of cinemas[1]

## Latest Price

- **Price:** ₹264.7
- **Change:** +2.2 (+0.84%)
- **Open:** ₹260.5
- **Day High:** ₹267.8
- **Day Low:** ₹252
- **Previous Close:** ₹262.5
- **Volume:** 52000
- **As Of:** 2026-09-11T10:01:44+00:00

## Key Fundamentals

Observed at 2026-09-11T04:45:08.147296Z.

- **Market Cap:** ₹481.32 Cr
- **Classification:** SME
- **P/E (reported):** 19.2
- **Book Value:** ₹70.33
- **Price to Book:** 3.73
- **Dividend Yield:** 0%
- **ROE:** 19.42%
- **ROCE:** 23.5%
- **Debt to Equity:** 0.01
- **Revenue (yearly):** ₹150.1 Cr
- **Net Income:** ₹26.1 Cr
- **EBITDA:** ₹37.5 Cr
- **52-Week High:** ₹311.9
- **52-Week Low:** ₹180
- **RSI (14):** 74.79

## Tapetide Score

- **Score:** 61 / 100
- **Score date:** 2026-09-04
- **Archetype:** Trend Ahead of Fundamentals
- **What it means:** The price trend is running ahead of what the financials currently support. Moves like this depend on the fundamentals catching up; check what would have to be true for that.
- **Pillar profile:** Quality: Weak · Valuation: Expensive · Momentum: Rising
- **Percentile:** 90.4 (of 4473 scored stocks)
- **Confidence:** 95%
- **Data coverage:** 90%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 85.21 | 9% |
| growth | 93.15 | 9% |
| momentum | 68.65 | 12% |
| ownership | 79.37 | 24% |
| quality | 41.51 | 22% |
| valuation | 41.79 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Company is almost debt free.
- Company has a good return on equity (ROE) track record: 3 Years ROE 49.1%

### Weaknesses

- Though the company is reporting repeated profits, it is not paying out dividend
- Debtor days have increased from 41.9 to 52.7 days.
- Working capital days have increased from 53.7 days to 90.8 days

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| ebitda margin growth | 13.6% | -11.79% | 125.95% | 14.11% |
| net income growth | 9.6% | 37.37% | 150% | — |
| revenue growth | 41.5% | 55.06% | 80% | 84.61% |
| roce | — | -58.74% | 17.97% | 23.63% |
| roe | — | -74.77% | 57.23% | -106.96% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
| --- | --- | --- | --- | --- |
| Sales | 41 | 55 | 64 | 83 |
| Expenses | 28 | 41 | 46 | 66 |
| Operating Profit | 13 | 13 | 18 | 17 |
| OPM % | 31 | 24 | 28 | 20 |
| Other Income | 1 | 0 | 1 | 2 |
| Interest | 0 | 0 | 0 | 0 |
| Depreciation | 1 | 1 | 1 | 1 |
| Profit before tax | 13 | 13 | 17 | 18 |
| Tax % | 25 | 27 | 25 | 26 |
| Net Profit | 10 | 9 | 13 | 13 |
| EPS in Rs | 191.8 | 6.7 | 6.83 | 6.82 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- |
| Sales | 7 | 25 | 60 | 96 | 148 |
| Expenses | 5 | 23 | 54 | 69 | 112 |
| Operating Profit | 1 | 3 | 6 | 26 | 35 |
| OPM % | 20 | 10 | 10 | 27 | 24 |
| Other Income | 0 | 0 | 1 | 1 | 2 |
| Interest | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 1 | 1 | 2 | 2 |
| Profit before tax | 1 | 2 | 6 | 26 | 35 |
| Tax % | 28 | 24 | 26 | 26 | 25 |
| Net Profit | 1 | 2 | 4 | 19 | 26 |
| EPS in Rs | 17 | 33 | 81.8 | 13.55 | 13.65 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- |
| Equity Capital | 0.5 | 0.5 | 0.5 | 14 | 19 |
| Reserves | -1 | 1 | 5 | 11 | 115 |
| Borrowings | 0 | 0 | 0 | 1 | 2 |
| Other Liabilities | 16 | 26 | 31 | 36 | 38 |
| Total Liabilities | 16 | 28 | 36 | 61 | 174 |
| Fixed Assets | 4 | 7 | 9 | 10 | 21 |
| CWIP | 1 | 3 | 3 | 2 | 2 |
| Investments | 3 | 5 | 5 | 9 | 66 |
| Other Assets | 7 | 13 | 19 | 40 | 85 |
| Total Assets | 16 | 28 | 36 | 61 | 174 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 1 | 9 | 4 | 3 | -67 |
| Cash from Investing Activity | -3 | -6 | -4 | -5 | -11 |
| Cash from Financing Activity | 0 | 0 | 0 | 0 | 84 |
| Net Cash Flow | -2 | 3 | 0 | -1 | 7 |
| Free Cash Flow | -2 | 3 | 1 | 1 | -79 |
| CFO/OP | 83 | 336 | 69 | 36 | -165 |

### Ratios

| Item | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- |
| Debtor Days | 47 | 18 | 23 | 50 | 53 |
| Inventory Days | 30 | 97 | 55 | 80 | 160 |
| Days Payable | 365 | 72 | 67 | 67 | 89 |
| Cash Conversion Cycle | -288 | 43 | 10 | 63 | 124 |
| Working Capital Days | 142 | 52 | 17 | 54 | 91 |
| ROCE % | — | 319 | 151 | 162 | 44 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2025 | Mar 2026 |
| --- | --- | --- |
| Promoters | 70.07% | 70.11% |
| FIIs | 2.47% | 0.72% |
| DIIs | 0.21% | 6.96% |
| Government | 0% | 0% |
| Public | 10.02% | 12.43% |
| Others | 17.23% | 9.78% |
| No. of Shareholders | 873 | 1166 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Buy
- **Buy / Neutral / Sell:** 13 / 2 / 4

### Moving Averages — summary: **Strong Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 239.87 | Buy |
| EMA (10) | 246.4 | Buy |
| SMA (20) | 230 | Buy |
| EMA (20) | 234.23 | Buy |
| SMA (50) | 213.57 | Buy |
| EMA (50) | 222.77 | Buy |
| SMA (100) | 223.85 | Buy |
| EMA (100) | 223.19 | Buy |
| SMA (200) | 236.98 | Buy |
| EMA (200) | 224.97 | Buy |

### Oscillators — summary: **Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 75.53 | Sell |
| MACD (12,26,9) | 13.36 | Buy |
| Stochastic (14,3,3) | 87.96 | Sell |
| ADX (14) | 37.12 | Buy |
| Williams %R (14) | -11.77 | Sell |
| ATR (14) | 12.43 | High Volatility |
| ROC (12) | 16.92 | Buy |
| Stoch RSI (14) | 89.67 | Sell |
| UO (7,14,28) | 55.44 | Neutral |

## Filings & Documents

### Other Documents

| Date | Document |
| --- | --- |
| 9 March 2026 - Yudiz: Special resolution approved March 6, 2026 to alter Memorandum object clause; 73.93% votes polled. | [Shareholders meeting 9 March 2026 - Yudiz: Special resolution approved March 6, 2026 to alter Memorandum object clause; 73.93% votes polled.](https://nsearchives.nseindia.com/corporate/YUDIZ_09032026180115_Intimation_of_Voting_Results.pdf) |
| 9 Aug - Connplex Cinemas opened a 3-screen, 302-seat cinema in Darbhanga, Bihar. | [General Updates 9 Aug - Connplex Cinemas opened a 3-screen, 302-seat cinema in Darbhanga, Bihar.](https://nsearchives.nseindia.com/corporate/CONNPLEX_09082026131830_Darbhanga_NSE_Letter-final_signed.pdf) |
| 8 July 2026 - Submitted Regulation 74(5) certificate for quarter ended June 30, 2026; demat requests processed within stipulated time. | [Certificate under SEBI (Depositories and Participants) Regulations, 2018 8 July 2026 - Submitted Regulation 74(5) certificate for quarter ended June 30, 2026; demat requests processed within stipulated time.](https://nsearchives.nseindia.com/corporate/CONNPLEX_08072026104334_Letter_final_signed.pdf) |
| 8 July 2026 - Connplex Cinemas says Regulation 27(2) corporate governance report is not applicable for quarter ended June 30, 2026. | [Quarterly Compliance Report on Corporate governance - within 21 days from the end of the quarter 8 July 2026 - Connplex Cinemas says Regulation 27(2) corporate governance report is not applicable for quarter ended June 30, 2026.](https://nsearchives.nseindia.com/corporate/CONNPLEX_08072026105639_Letter_final_signed.pdf) |
| 8 April 2026 - Regulation 74(5) compliance certificate for quarter ended March 31, 2026. | [Certificate under SEBI (Depositories and Participants) Regulations, 2018 8 April 2026 - Regulation 74(5) compliance certificate for quarter ended March 31, 2026.](https://nsearchives.nseindia.com/corporate/CONNPLEX_08042026114538_Int_74_5.pdf) |
| 8 April 2026 - Connplex Cinemas հայտնում Regulation 27(2) corporate governance provisions not applicable for quarter ended March 31, 2026. | [Quarterly Compliance Report on Corporate governance - within 21 days from the end of the quarter 8 April 2026 - Connplex Cinemas հայտնում Regulation 27(2) corporate governance provisions not applicable for quarter ended March 31, 2026.](https://nsearchives.nseindia.com/corporate/CONNPLEX_08042026121206_Intimation_-_Not_applicable_CG_Report.pdf) |
| 7 Sep - Board meets Sept. 11, 2026 to consider preferential issue of equity shares/convertible warrants. | [Trading Window 7 Sep - Board meets Sept. 11, 2026 to consider preferential issue of equity shares/convertible warrants.](https://nsearchives.nseindia.com/corporate/CONNPLEX_07092026170755_Prior_Intimation_of_Board_Meeting_s.pdf) |
| 7 May 2026 - Connplex Cinemas will hold H2FY26 earnings call on May 12, 2026 for audited results. | [Analysts/Institutional Investor Meet/Con. Call Updates 7 May 2026 - Connplex Cinemas will hold H2FY26 earnings call on May 12, 2026 for audited results.](https://nsearchives.nseindia.com/corporate/CONNPLEX_07052026213420_Intimationinvestorcall.pdf) |
| 7 April 2026 - India Patent Office granted 20-year patent for 'Active LED/LED Screen Integrated with Non-DCI Servers'. | [General Updates 7 April 2026 - India Patent Office granted 20-year patent for 'Active LED/LED Screen Integrated with Non-DCI Servers'.](https://nsearchives.nseindia.com/corporate/CONNPLEX_07042026172032_NSE_Letter.pdf) |
| 6 February 2026 - Feb 5, 2026 postal ballot: special resolution to vary IPO proceeds passed unanimously; scrutinizer report uploaded. | [Shareholders meeting 6 February 2026 - Feb 5, 2026 postal ballot: special resolution to vary IPO proceeds passed unanimously; scrutinizer report uploaded.](https://nsearchives.nseindia.com/corporate/CONNPLEX_06022026142509_Votingresult_06022026.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from nse | [Annual Report 2026 from nse](https://archives.nseindia.com/annual_reports/SME_AR_30479_CONNPLEX_2025_2026_A_5946348_21082026142259.pdf) |
| from nse | [Financial Year 2025 from nse](https://archives.nseindia.com/annual_reports/SME_AR_28949_YUDIZ_2024_2025_A_1411804_08092025191553.pdf) |
| from nse | [Financial Year 2024 from nse](https://archives.nseindia.com/annual_reports/SME_AR_26174_YUDIZ_2023_2024_07092024185856.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Nov 2025 | [Concall - Nov 2025](https://nsearchives.nseindia.com/corporate/CONNPLEX_17112025102037_TrascriptH1FY26.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T19:29:34.398Z.